Home Page  
    Advanced
Search
Home Page Corporate Services Careers Specialties Strategic Alliances Events & Speakers Investigators Study Volunteers Contact

  All Services

>Preclinical

      Strategic Development

    >Preclinical Evaluation

          AAALAC Accredited

          Human Tumor
          Xenografts

          Angiogenesis Models

        >Radioactivity

          In Vitro and Biomarker
          Capabilities

          Acute Toxicity and PK

          Hematology Analysis

          Corneal Micropocket
          Assay

          Cachexia Model

          Intratibial Tumor Model

          Neurotoxicity Model

          Orthotopic Models

      CMC Consulting

      Pharm/Tox Consulting

      Regulatory Submissions

  Phase I

  Phase II-IIIb

  Post-Approval

  Labs

Radioactivity

To help determine the targeting and tumor specificity of a client's agent, Piedmont Research Center is licensed to carry out biodistribution studies with C and H labeled molecules.

For targeted radiolabeled therapeutics,Y tagged compounds can also be used.

PPD Preclinical Services